Medtronic Seeks InFuse Add-on, Proposes Clearer Definition Of “Similarity”

CMS should reconsider granting new technology add-on payment for Medtronic's InFuse bone graft for tibia fractures by using a clearer definition of "substantial improvement," according to the company

More from Archive

More from Medtech Insight